Health Condition 1: M205- Other deformities of toe(s) (acquired)
Conditions
Interventions
None listed
Sponsors
RAJIV GANDHI GOVERNMENT POST GRADUATION COLLEGE AND HOSPITAL PAPROLA
Eligibility
Inclusion criteria
Inclusion criteria: 1 Patient of either gender in the age group between 30 to 60 years. 2 Patients having serum uric acid level more than 7 mg per dl in male and more than 6 mg per dl in female with or without any associated features of joint inflammation. 3 Willing to participate and able to provide signed informed consent.
Exclusion criteria
Exclusion criteria: 1 Patients not willing for the trial. 2 Patient suffering from any other form of arthritis like osteoarthritis, tubercular arthritis, rheumatoid arthritis etc. 3 Patients suffering from uncontrolled diabetes, chronic renal diseases, respiratory illness, serious cardiac and hepatic disorders. 4 Patients having any active malignancy. 5 Patients who have completed participation in any other clinical trial during the past 3 months. 6 Any condition which the principal investigator thinks may jeopardize the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy of Guduchi Churna and Dhatrayadi Kwatha in the management of Vatarakta w.s.r. to Hyperuricemia.Timepoint: 60 days | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the efficacy of Guduchi Churna and Dhatrayadi Kwatha with Febuxostat in the management of Vatarakta w.s.r. to Hyperuricemia. To assess the clinical safety of Guduchi Churna and Dhatrayadi Kwatha in the management of Vatarakta w.s.r. to Hyperuricemia. Timepoint: 60 days | — |
Countries
India
Contacts
Public ContactDr Anjali Sharma
RAJIV GANDHI GOVT PG AYURVEDIC COLLEGE AND HOSPITAL PAPROLA
Outcome results
None listed